Novocure Stock Analysis

Novocure Stock Analysis Notes

About 86.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 721.15. Novocure recorded a loss per share of 1.39. The entity had not issued any dividends in recent years. NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey. NovoCure operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1167 people. To find out more about Novocure contact Asaf Danziger at 44 15 3475 6700 or learn more at https://www.novocure.com.

Novocure Investment Alerts

Novocure Upcoming and Recent Events

Novocure Largest EPS Surprises

View All Earnings Estimates

Novocure Environmental, Social, and Governance (ESG) Scores

Novocure Thematic Classifications

Novocure Stock Institutional Investors

Note, although Novocure's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Novocure Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.43 B.

Novocure Profitablity

The company has Profit Margin (PM) of (0.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.21.

Management Efficiency

Novocure has return on total asset (ROA) of (0.0793) % which means that it has lost $0.0793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3971) %, meaning that it created substantial loss on money invested by shareholders. Novocure's management efficiency ratios could be used to measure how well Novocure manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/16/2025, Return On Tangible Assets is likely to drop to -0.17. In addition to that, Return On Capital Employed is likely to drop to -0.23. At this time, Novocure's Total Assets are relatively stable compared to the past year. As of 02/16/2025, Non Current Assets Total is likely to grow to about 134.9 M, while Other Current Assets are likely to drop slightly above 6.6 M.

Technical Drivers

As of the 16th of February 2025, Novocure secures the Downside Deviation of 3.53, mean deviation of 3.55, and Risk Adjusted Performance of 0.068. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novocure, as well as the relationship between them. Please verify Novocure jensen alpha and downside variance to decide if Novocure is priced some-what accurately, providing market reflects its recent price of 22.48 per share. Given that Novocure has jensen alpha of 0.5763, we recommend you to check Novocure's last-minute market performance to make sure the company can sustain itself at a future point.

Novocure Price Movement Analysis

Novocure Insider Trading Activities

Novocure Outstanding Bonds

Novocure Predictive Daily Indicators

Novocure Corporate Filings

Novocure Forecast Models

Novocure's time-series forecasting models are one of many Novocure's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novocure's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Novocure prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novocure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novocure. By using and applying Novocure Stock analysis, traders can create a robust methodology for identifying Novocure entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Novocure analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Novocure analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Novocure stock analysis indicators help investors evaluate how Novocure stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Novocure shares will generate the highest return on investment. By understating and applying Novocure stock analysis, traders can identify Novocure position entry and exit signals to maximize returns.

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.